HKU Scholars Hub: Browsing DSpace

Browsing by Author Peng, CY

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 15 of 15

	Title	Author(s)	Issue Date	Views
	Cu(OH)2 supported on Fe(OH)3 as a synergistic and highly efficient system for the dehydrogenation of ammonia-borane Journal:Science Bulletin	Peng, CY Hou, CC Chen, QQ Wang, CJ Lv, XJ Zhong, J Fu, WF Che, CM Chen, Y	2018
	Early hepatitis B virus DNA reduction in hepatitis B e antigen-positive patients with chronic hepatitis B: A randomized international study of entecavir versus adefovir Journal:Hepatology	Leung, N Peng, CY Hann, HW Sollano, J LaoTan, J Hsu, CW Lesmana, L Yuen, MF Jeffers, L Sherman, M Min, A Mencarini, K Diva, U Cross, A Wilber, R LopezTalavera, J	2009
	Entecavir (ETV) Results in Higher HBV-DNA Reduction vs Adefovir (ADV) In Chronically Infected HBeAg(+) Antiviral-Naive Adults: 48-Week Results (E.A.R.L.Y. STUDY) Proceeding/Conference:Digestive Disease Week	Leung, N Sherman, M Peng, CY Sollano, JD Lesmana, L Yuen, RMF Jeffers, L Hann, HW Menearini, K Colonno, R Cross, A Wilber, R Lopez-Talavera, JC	2007	63
	Entecavir (ETV) Therapy in Chronic Hepatitis B Patients Previously Treated with Adefovir (ADV) with Incomplete Response On-Treatment or Relapse Off-Treatment Proceeding/Conference:Gastroenterology	Lai, CL Elion, RA Sherman, M Hann, HW Tyrell, DL Hsu, CW Tan, CK Peng, CY Leung, N Mencarini, KA Zhang, H Iloeje, UH Kreter, B	2009	17
	Entecavir (ETV) therapy in chronic hepatitis B patients previously treated with adefovir (ADV) with incomplete response on-treatment or relapse off-treatment Proceeding/Conference:Journal of Hepatology	Lai, CL Elion, R Sherman, M Hann, HW Tyrell, DL Hsu, CW Tan, CK Peng, CY Leung, N Mercarni, K Zhang, H Iloeje, UH Kreter, B	2009	84
	Entecavir (ETV) vs. Adefovir (ADV): HBV DNA reduction of viral load in chronically infected HBeAg(+) nucleoside naive adults in a 12-week Proceeding/Conference:Journal of clinical virology	Sherman, M Hann, HW Jeffers, L Min, A Leung, N Peng, CY Liaw, YF Sollano, J Lesmana, L Yuen, RMF Zhu, J Mencarini, K Colonno, R Cross, A Wilber, R Lopez-Talavera, JC	2006	66
	Entecavir results in higher HBV DNA reduction vs adefovir in chronically infected HBeAg(+) antiviral-naive adults: 24 wk results (EARLY study) Proceeding/Conference:Hepatology	Leung, N Peng, CY Sollano, J Lesmana, L Yuen, RMF Jeffers, L Han, HW Sherman, M Zhu, J Menearini, K Colonno, RJ Cross, A Wilber, R Lopez-Talavera, JC	2006	56
	Improved Bone Safety of Tenofovir Alafenamide Compared to Tenofovir Disoproxil Fumarate Over 2 Years in Patients With Chronic HBV Infection Journal:Clinical Gastroenterology and Hepatology	Seto, WKW Asahina, Y Brown, TT Peng, CY Stanciu, C Abdurakhmanov, D Tabak, F Nguyen, TT Chuang, WL Inokuma, T Ikeda, F Santantonio, TA Habersetzer, F Ramji, A Lau, AH Suri, V Flaherty, JF Wang, H Gaggar, A Subramanian, GM Mukewar, S Brunetto, MR Fung, S Chan, HL	2018
	Phase 3, randomized, double-blind, dummy-controlled, trial of radiofrequency ablation (RFA) + lyso-thermosensitive liposomal doxorubicin (LTLD, Thermodox), for hepatocellular carcinoma (HCC) lesions 3-7 cm Proceeding/Conference:Annual Conference of the International Liver Cancer Association, ILCA 2013	Tak, WY Lin, SM Wang, Y Zheng, J Izzo, F Park, SY Chen, MH Wong, SN Xu, R Peng, CY Chiou, YY Huang, GT Lee, JY Sherman, M Abdullah, BJJ Lee, JS Wang, JH Borys, N Poon, RTP Lencioni, R	-	218
	REAL-B (Real-world Effectiveness from the Asia Pacific Rim Liver Consortium for HBV) - A Risk Score for the Prediction of Hepatocellular Carcinoma (HCC) in Chronic Hepatitis (CHB) Patients Treated with Oral Anti-HBV Therapy Proceeding/Conference:Hepatology	Nguyen, MH Yang, HI Yeh, ML Wong, GL Peng, CY Chen, CH Trinh, HN Cheung, KSM Su, TH Kozuka, R Ogawa, E Li, J Zhang, JQ Wong, C Wong, Clifford Prasad, D Hoang, J Lin, CH Ueno, Y Gane, EJ Xing, H Furusyo, N Enomoto, M Kao, JH Yuen, RMF Yu, ML	2017	15
	Real-World Effectiveness From the Asia Pacific Rim Liver Consortium for HBV Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated With Oral Antiviral Therapy Journal:The Journal of Infectious Diseases	Yang, HI Yeh, ML Wong, GL Peng, CY Chen, CH Trinh, HN Cheung, KS Xie, Q Su, TH Kozuka, R Lee, DH Ogawa, E Zhao, C Ning, HB Huang, R Li, J Zhang, JQ Ide, T Xing, H Iwane, S Takahashi, H Wong, C Wong, C Lin, CH Hoang, J Le, A Henry, L Toyoda, H Ueno, Y Gane, EJ Eguchi, Y Kurosaki, M Wu, C Liu, C Shang, J Furusyo, N Enomoto, M Kao, JH Yuen, MF Yu, ML Nguyen, MH	2020
	Reduced changes in bone mineral density in Chronic HBV (CHB) Patients receiving Tenofovir Alafenamide (TAF) compared with Tenofovir Disoproxil Fumarate (TDF) Proceeding/Conference:The Liver Meeting® 2016	Seto, WKW Asahina, Y Peng, CY Stanciu, C Abdurakhmanov, D Flaherty, J Kim, K Gaggar, A Subramanian, M Tabak, F Nguyen, TT Chan, HLY	2016	30
	Reduced changes in bone mineral density in chronic hepatitis B patients receiving TAF compared with TDF Proceeding/Conference:Conference of the Asian Pacific Association for the Study of the Liver, APASL 2017	Seto, WKW Asahina, Y Peng, CY Stanciu, C Abdurakhmanov, D Flaherty, J Kim, L Gaggar, A Subramanian, M Tabak, F Nguyen, TT Chan, HLY	2017	10
	Tenofovir Versus Entecavir for Hepatocellular Carcinoma Prevention in an International Consortium of Chronic Hepatitis B Journal:The American Journal of Gastroenterology	Hsu, YC Wong, GLH Chen, CH Peng, CY Yeh, ML Cheung, KS Toyoda, H Huang, CF Trinh, H Xie, Q Enomoto, M Liu, L Yasuda, S Tanaka, Y Kozuka, R Tsai, PC Huang, YT Wong, C Huang, R Jang, TY Hoang, J Yan, HI Li, J Lee, DH Takahashi, H Zhang, JQ Ogawa, E Zhao, C Liu, C Furusyo, N Eguchi, Y Wong, C Wu, C Kumada, T Yuen, MF Yu, ML Nguyen, M	2020
	Ternary Ni–Co–P nanoparticles as noble-metal-free catalysts to boost the hydrolytic dehydrogenation of ammonia-borane Journal:Energy & Environmental Science	Hou, CC Li, Q Wang, CJ Peng, CY Chen, QQ Ye, HF Fu, WF Che, CM Núria, L Chen, Y	2017	6

Showing results 1 to 15 of 15